Results 211 to 220 of about 352,162 (366)
Glucose-6 Phosphate Dehydrogenase (G-6-PD) Status, Aflatoxins and Neotanal Jaundice
Summary: In the present study of G-6 PD status, aflatoxins and neonatal jaundice, involving, 78 jaundiced and control in-born babies and 124 jaundiced and control out-born infants, G-6 PD was deficient in more male jaundiced babies (in-and out-borns ...
Ahmed H +3 more
doaj
Malaria, glucose-6-phosphate dehydrogenase deficiency, and Hb S. [PDF]
Peter Beaconsfield
openalex +1 more source
Micro disc electrophoresis and quantitative assay of glucose-6-phosphate dehydrogenase at the cellular level [PDF]
Cremer, Thomas, Dames, W., Neuhoff, V.
core +1 more source
A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus
Objective Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus erythematosus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity, and incidence of SLE.
Nancy J. Olsen +14 more
wiley +1 more source
A clinical algorithm to identify people with the glucose-6-phosphate dehydrogenase p.Val68Met variant at risk for diabetes undertreatment. [PDF]
Pershad Y +9 more
europepmc +1 more source
Objective Systemic lupus erythematosus (SLE) is characterized by increased type I interferon (IFN‐I) and autoantibody production. This study aimed to identify drugs that can inhibit both IFN‐I and autoantibody production. Methods We identified an inhibitor of IFN‐I production from a chemical library.
Takehiro Hirayama +16 more
wiley +1 more source
Upadacitinib-Induced Hemolysis in a Patient With Glucose-6-Phosphate Dehydrogenase Deficiency-A Possible Adverse Drug Reaction. [PDF]
Patanè L +5 more
europepmc +1 more source

